LUDWIG HANTSON

Insider Reports History

Location
New Haven, CT
Signature
/s/ Mark W. Irving, attorney-in-fact for Dr. Hantson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by LUDWIG HANTSON:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALEXION PHARMACEUTICALS, INC. CEO, Director Common Stock, par value $.0001 per share 9,098 $1,610,346 $177.00 21 Jul 2021 Direct
HOLOGIC INC Director Common Stock 12,956 $954,209 $73.65 26 Feb 2025 Direct
HOLOGIC INC Director Non-qualified Stock Option (Right to Buy) 5,535 26 Feb 2025 Direct
HOLOGIC INC Director Non-qualified Stock Option (Right to Buy) 4,536 07 Mar 2024 Direct
ALEXION PHARMACEUTICALS, INC. CEO, Director Option to Purchase Common Stock 0 $155.01 21 Jul 2021 Direct

Insider Reports Filed by LUDWIG HANTSON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HOLX HOLOGIC INC 26 Feb 2025 2 $0 4 Director 28 Feb 2025, 16:18
HOLX HOLOGIC INC 07 Mar 2024 2 $0 4 Director 11 Mar 2024, 17:54
HOLX HOLOGIC INC 09 Mar 2023 2 $0 4 Director 13 Mar 2023, 16:16
HOLX HOLOGIC INC 10 Mar 2022 2 $0 4 Director 14 Mar 2022, 16:26
/report/000089986621000063-hantson-ludwig-2021-07-21 ALEXION PHARMACEUTICALS, INC. 21 Jul 2021 2 -$6,745,028 4 CEO, Director 23 Jul 2021, 16:32
/report/000089986621000058-hantson-ludwig-2021-07-14 ALEXION PHARMACEUTICALS, INC. 14 Jul 2021 2 $0 4 CEO, Director 16 Jul 2021, 16:56